These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 38695859)

  • 1. MYC activity at enhancers drives prognostic transcriptional programs through an epigenetic switch.
    Jakobsen ST; Jensen RAM; Madsen MS; Ravnsborg T; Vaagenso CS; Siersbæk MS; Einarsson H; Andersson R; Jensen ON; Siersbæk R
    Nat Genet; 2024 Apr; 56(4):663-674. PubMed ID: 38454021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel oncogenic enhancer of estrogen receptor-positive breast cancer.
    Bao C; Duan J; Xie Y; Liu Y; Li P; Li J; Zhao H; Guo H; Men Y; Ren Y; Xu J; Wang G; Lu W
    Mol Ther Nucleic Acids; 2022 Sep; 29():836-851. PubMed ID: 36159594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitive nascent transcript sequencing reveals BRD4-specific control of widespread enhancer and target gene transcription.
    Bressin A; Jasnovidova O; Arnold M; Altendorfer E; Trajkovski F; Kratz TA; Handzlik JE; Hnisz D; Mayer A
    Nat Commun; 2023 Aug; 14(1):4971. PubMed ID: 37591883
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    See YX; Chen K; Fullwood MJ
    Genome Res; 2022 Apr; 32(4):629-642. PubMed ID: 35115371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional
    Park A; Oh S; Jung KL; Choi UY; Lee HR; Rosenfeld MG; Jung JU
    Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21618-21627. PubMed ID: 32817485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hold the MYCrophone: MYC Invades Enhancers to Control Cancer Type Gene Programs.
    MacPherson-Hawthorne KA; Sears RC
    Cancer Res; 2024 May; ():. PubMed ID: 38695859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets.
    Bacabac M; Xu W
    Cancer Metastasis Rev; 2023 Jun; 42(2):471-480. PubMed ID: 37059907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Super-Enhancers, Phase-Separated Condensates, and 3D Genome Organization in Cancer.
    Tang SC; Vijayakumar U; Zhang Y; Fullwood MJ
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancers and MYC interplay in hematopoiesis.
    Benetatos L; Benetatou A; Vartholomatos G
    J Mol Med (Berl); 2020 Apr; 98(4):471-481. PubMed ID: 32144465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Super-enhancers in cancer.
    Thandapani P
    Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting super-enhancer activity for colorectal cancer therapy.
    Voutsadakis IA
    Am J Transl Res; 2024; 16(3):700-719. PubMed ID: 38586095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancer RNAs: a missing regulatory layer in gene transcription.
    Mao R; Wu Y; Ming Y; Xu Y; Wang S; Chen X; Wang X; Fan Y
    Sci China Life Sci; 2019 Jul; 62(7):905-912. PubMed ID: 30593613
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.